Ox brain versus rabbit brain thromboplastin assays are the best tool for a preliminary diagnosis of the Arg304Gln factor VII defect (FVII Padua)

Acta Haematologica

Volumn 124, Issue 4, 2010, Pages 229-234

  Girolami, A ^a   Berti De Marinis, G ^a   Bonamigo, E ^a   Sartori, R ^b   Vettore, S ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Blood Transfusion Center   (Italy)

Author keywords

Arg304Gln mutation; Factor VII levels; Tissue thromboplastins

Indexed keywords

BLOOD CLOTTING FACTOR 7; RECOMBINANT THROMBOPLASTIN; THROMBIN;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BRAIN; CLINICAL ARTICLE; HOMOZYGOSITY; HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTHROMBIN TIME; RABBIT;

AMINO ACID SUBSTITUTION; ANIMALS; ARGININE; BRAIN CHEMISTRY; CATTLE; FACTOR VII; GLUTAMINE; HOMOZYGOTE; HUMANS; RABBITS; THROMBOPLASTIN;

EID: 78449254568     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321534     Document Type: Article

References (37)

1. Alexander B, Goldstein R, Landwehr G, Cook CD: Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions. J Clin Invest 1951; 30: 596-608.
2. Perry DJ: Factor VII deficiency. Br J Haematol 2002; 118: 689-700.
3. Herrmann FH, Wulff K, Auerswald G, Schulman S, Astermark J, Batorova A, Kreuz W, Pollmann H, Ruiz-Saez A, Bosch N, Salazar-Sanchez L: Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Haemophilia 2009; 15: 267-280.
4. Triplett DA, Brandt JT, Batard MA, Dixon JL, Fair DS: Hereditary factor VII eficiency: heterogeneity defined by combined functional and immunochemical analysis. Blood 1985; 66: 1284-1287.
5. Girolami A, Fabris F, Dal Bo Zanon R, Ghiotto G, Burul A: Factor VII Padua: a ongenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. J Lab Clin Med 1978; 91: 387-395.
6. Girolami A, Patrassi G, Cappellato G, Casonato A: Another family with the factor VII Padua clotting defect. Acta Haematol 1979; 62: 4-11.
7. Girolami A, Gaio A, Doglioni L, Procidano M, Saltarin P: Further studies on factor VII Padua defect: the report of the fourth homozygous patient from the same valley. Blut 1982; 44: 363-369.
8. Girolami A, Dal Bo Zanon R, Caenazzo A, Scattolo N: Report of the fifth homozygous patient with factor VII Padua defect. Folia Haematol Int Mag Klin Morphol Blutforsch 1983; 110: 447-454.
9. James HL, Kumar A, Girolami A, Hubbert J, Fair D: Variant coagulation Factor X and II with point mutations in a highly conserved motif in the substrate binding pocket (abstract). Comparative molecular modelling. Thromb Hemost 1991; 65: 937.
10. O'Brien DP, Gale KM, Anderson JS, McVey JH, Miller GJ, Meade TW, Tuddenham EG: Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male. Blood 1991; 78: 132-140.
11. Croze M, Brizard CP: Factor VII Padua 1. Another case. Haemostasis 1982; 11: 185-188.
12. James HL, Girolami A, Hubbard JG, Kumar A, Fair DS: The dysfunction of coagulation factor VII Padua results from substitution of arginine-304 by glutamine. Biochim Biophys Acta 1993; 1172: 301-305.
13. Peyvandi F, Jenkins PV, Mannucci PM, Billio A, Zeinali S, Perkins SJ, Perry DJ: Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency. Thromb Haemost 2000; 84: 250-257.
14. Kernoff LM, Hughes J, Denson KW: Congenital factor VII deficiency. Clinical and laboratory characteristics of a newly discovered kindred. Clin Lab Haematol 1982; 4: 109-115.
15. Girolami A, Dal Bo Zanon R, Zanella F, Procidano M, Ruffato G: Factor VII Padua defect: the heterozygote population. Acta Haematol 1982; 68: 34-38.
16. Girolami A, Dal Bo Zanon R, Caenazzo A, Scattolo N: Report of the fifth homozygous patient with factor VII Padua defect. Folia Haematol 1983; 110: 447-454.
17. Girolami A, Scandellari R, Scapin M, Vettore S: Congenital bleeding disorders of the vitamin K-dependent clotting factors. Vitam Horm 2008; 78: 281-374.
18. Girolami A, Sartori MT, Steffan A, Fadin MA: Recombinant thromboplastin is slightly more sensitive to factor VII Padua than standard thromboplastins of human origin. Blood Coagul Fibrinolysis 1993; 4: 497-498.
19. Fromovich-Amit Y, Zivelin A, Rosenberg N, Tamary H, Landau M, Seligsohn U: Characterization of mutations causing factor VII deficiency in 61 unrelated Israeli patients. J Thromb Haemost 2004; 2: 1774-1781.
20. Fromovich-Amit Y, Zivelin A, Rosenberg N, Landau M, Rosa JP, Seligsohn U: Of four mutations in the factor VII gene in Tunisian patients, one novel mutation (Ser339Phe) in three unrelated families abrogates factor X activation. Blood Coagul Fibrinolysis 2005; 16: 369-374.
21. Bernardi F, Liney DL, Patracchini P, Gemmati D, Legnani C, Arcieri P, Pinotti M, Redaelli R, Ballerini G, Pemberton S, Wacey AI, Mariani G, Tuddenham GB, Marchetti G: Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII. Br J Haematol 1994; 86: 610-618.
22. Giansily-Blaizot M, Aguilar-Martinez P, Biron- Andreani C, Jeanjean P, Igual H, Schved JF, Study Group of Factor Seven Deficiency: Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency. Eur J Hum Genet 2001; 9: 105-112.
23. Takamiya O, McVey I, Kemhell-Cook G, Tuddenham E: Disfunctional human FVII variants and single-strand conformational polymorphism (SSC5) (abstract). Thromb Hemost 1993; 69(suppl):1291.
24. Tahatahary A, Ravanbod S, Baghaipour M, Enayar M, Ala F, Rastager-Iari: Factor VII genotype and clinical profile in 6 Iranian patients with congenital factor VII deficiency (abstract). J Thromb Hemost 2007; 5(suppl): 208.
25. Sabharwal A, KuppusWarmy M, Foster D, Wildgoose P, Fisher L, Birktoft J, Bajaj S: Factor VII deficiency (FVII Richmond) associated with thrombosis (abstract). Circul 1992; 88(suppl):679.
26. Arbini AA, Bodkin D, Lopaciuk S, Bauer KA: Molecular analysis of Polish patients with factor VII deficiency. Blood 1994; 84: 2214-2220.
27. Wulff K, Herrmann FH: Twenty two novel mutations of the factor VII gene in factor VII deficiency. Hum Mutat 2000; 15: 489-496.
28. Mota L, Shetty S, Idicula-Thomas S, Ghosh K: Phenotypic and genotypic characterization of factor VII deficiency patients from Western India. Clin Chim Acta 2009; 409: 106-111.
29. Rodrigues DN, Siqueira LH, Galizoni AM, Arruda VR, Annichino-Bizzacchi JM: Prevalence of factor VII deficiency and molecular characterization of the F7 gene in Brazilian patients. Blood Coagul Fibrinolysis 2003; 14: 289-292.
30. Owren PA: The interrelationship between Normotest and Thrombotest. Farmakotherai 1969; 25: 1-13.
31. Girolami A, Brunetti A, Patrassi GM: Normotest- thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex and in coumarin-treated patients: a nonspecific phenomenon. Am J Clin Pathol 1977; 67: 57-60. (Pubitemid 8025623)
32. Etro D, Pinotti M, Wulff K, Marchetti G, Rocino A, Herrmann FH, Bernardi F: The Gly331Ser mutation in factor VII in Europe and the Middle East. Haematologica 2003; 88: 1434-1436.
33. Millar DS, Kemball-Cook G, McVey JH, Tuddenham EG, Mumford AD, Attock GB, Reverter JC, Lanir N, Parapia LA, Reynaud J, Meili E, von Felton A, Martinowitz U, Prangnell DR, Krawczak M, Cooper DN: Molecular analysis of the genotype-phenotype relationship in factor VII deficiency. Hum Genet 2000; 107: 327-342.
34. Takamiya O, Kimura S: Molecular mechanism of dysfunctional factor VII associated with the homozygous missense mutation 331Gly to Ser. Thromb Haemost 2005; 93: 414-419.
35. Mariani G, Herrmann FH, Schulman S, Batorova A, Wulff K, Etro D, Dolce A, Auerswald G, Astermark J, Schved JF, Ingerslev J, Bernardi F, International Factor VII Deficiency Study Group: Thrombosis in inherited factor VII deficiency. J Thromb Haemost 2003; 1: 2153-2158.
36. Stief TW, Wieczerzak A, Renz H: Influence of coagulation factors on extrinsic thrombin generation. Blood Coagul Fibrinolysis 2007; 18: 105-112. (Pubitemid 46232829)
37. Matsushita T, Kojima T, Emi N, Takahashi I, Saito H: Impaired human tissue factor-mediated activity in blood clotting factor VIINagoya (Arg304 ] Trp). Evidence that a region in the catalytic domain of factor VII is important for the association with tissue factor. J Biol Chem 1994; 269: 7355-7363.